期刊文献+

肉毒毒素注射尿道外括约肌对逼尿肌-尿道外括约肌失协调患者逼尿肌厚度的影响 被引量:6

The effect of botulinum toxin injection to the external urethral sphincter on detrusor wall thickness in pa- tients with detrusor-sphincter dyssynergia
原文传递
导出
摘要 目的观察肉毒毒素A(BTX-A)注射尿道外括约肌对脊髓损伤后逼尿肌-尿道外括约肌收缩失协调(DSD)患者逼尿肌厚度及膀胱功能的影响。方法选取脊髓损伤后DSD成年患者21例,所有患者均在会阴超声引导下向尿道外括约肌注射BTX-A(100U)。于治疗前、治疗后4周、8周时进行尿动力学检查和下尿道超声评估,测定患者逼尿肌厚度、逼尿肌漏尿点压、残余尿量及最大膀胱容量。结果治疗后4周时人选患者残余尿量显著下降(P〈0.05),而逼尿肌厚度、逼尿肌漏尿点压及最大膀胱容量均无明显改变(P〉0.05)。治疗后8周时入选患者逼尿肌厚度为(0.93±0.17)mm,较治疗前下降了17.2%(P〈0.05);逼尿肌漏尿点压、残余尿量及最大膀胱容量亦较治疗前明显改善(P〈0.05)。结论在超声引导下向尿道外括约肌注射BTX-A可显著降低脊髓损伤后DSD患者逼尿肌厚度,改善膀胱功能,该疗法值得临床推广、应用。 Objective To evaluate the effect of injecting botulinum toxin A (BTX-A) to the external ure- thral sphincter on detrusor wall thickness (DWT) and the bladder function of spinal cord injury patients with detru- sor-sphincter dyssynergia ( DSD). Methods Twenty-one adult patients with DSD due to spinal cord injury were re- cruited. A single 100 IU dose of botulinum toxin A was injected into their external urethral sphincters via an ultra- sound-guided transperineal route. DWT, detrusor leak-point pressure (DLPP) , post-void residual volume (PRV) and maximum bladder capacity (MBC) were assessed by urodynamic examination and uhrasound evaluation before and 4 and 8 weeks after the injection. Results Four weeks later a significant decrease in PRV was observed, but no significant difference in DWT, DLPP or MBC. After eight weeks the mean DWT value had decreased by 17%, a sig- nificant reduction. There were also significant improvements in DLPP, PRV and MBC at eight weeks compared with the of baseline values. Conclusions BTX-A injection to the external urethral sphincter can reduce DWT and im- prove bladder function in spinal cord injury patients with DSD.
出处 《中华物理医学与康复杂志》 CAS CSCD 北大核心 2016年第6期421-424,共4页 Chinese Journal of Physical Medicine and Rehabilitation
基金 Cyrus Tang Foundation(USA)资助
关键词 肉毒毒素A 逼尿肌厚度 脊髓损伤 逼尿肌一尿道外括约肌失协调 Botulinum toxin A Detrusor wall thickness Spinal cord injury Detrusor-sphincter dyssynergia
  • 相关文献

参考文献20

  • 1de Groat WC, Yoshimura N. Mechanisms underlyin$ the recovery of lower urinary tract function following spinal cord injury[ J] .Prog Brain Res ,2006,152 : 59-84.
  • 2朱红军,张大伟,昝云强,刘传道,冯金法,沈卫东,杨卫新.脊髓损伤患者逼尿肌厚度与下尿道功能的关系[J].中华物理医学与康复杂志,2014,36(3):185-189. 被引量:9
  • 3杨卫新,苏敏,张大伟,朱红军,冯金法,陈庆梅.超声引导肉毒毒素注射尿道外括约肌治疗下尿路功能障碍[J].中华物理医学与康复杂志,2013,35(4):286-289. 被引量:8
  • 4Habchi H, Galaup JP, Morel-Journel N, et al. Botulinum A toxin and detrusor sphincter dyssynergia: retrospective study of 47 patients [ J ]. Prog Urol, 2014,24 (4) : 234-239.
  • 5de Groat WC ,Yoshimura N.Plastieity in reflex pathways to the lower u- rinary tract following spinal cord injury [ J ]. Exp Neurol, 2012, 235 ( 1 ) : 123-132.
  • 6Merrill L, Girard B, Arms L, et al. Neuropeptide/reeeptor expression and plasticity in micturition pathways [ J ]. Curr Pharm Des, 2013,19 (24) :4411-4422.
  • 7Mahfouz W, Coreos J. Management of detrusor external sphincter dys- synergia in neurogenic bladder[ J ] .Eur J Phys Rehabil Med, 2011,47 (4) :639-650.
  • 8Dykstra DD, Sidi AA.Treatment of detrusor-sphincter dyssynergia with botulinum A toxin : a double-blind study [ J ]. Arch Phys Med Rehabil, 1990,71(1) : 24-26.
  • 9Cruz F.Targets for botulinum toxin in the lower urinary tract[ J] .Neu- rourol Urodyn, 2014,33 ( 1 ) : 31-38.
  • 10Chancellor MB, Fowler C J, Apostolidis A, et al. Drug insight : biological effects of botulinum toxin A in the lower urinary tract [ J]. Nat Clin Pract Urol, 2008,5 (6) : 319-328.

二级参考文献37

  • 1Scott AB, Kennedy RA, Stubbs HA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol, 1985,103:347-350.
  • 2Hesse S, Lucke D, Malezic M, et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry, 1994,57 : 1321-1324.
  • 3Dykstra DD, Sidi AA, Scott AB, et al. Effects of botulinumA toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol, 1988,139:919-922.
  • 4Kuo HC. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Uro1,2003,170 : 1908-1912.
  • 5Chen SL, Bih LI, Chen GD, et al. Comparing a transrectal ultrasound- guided with a cystoscopy-guided botulinum toxin A injection in treating detrusor external sphincter dyssynergiain spinal cord injur'jl Am J Phys Med Rehabi1,2011,90 :723-730.
  • 6Petit H, Wiart L, Gaujard E, et al. Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord, 1998,36:91-94.
  • 7Fowler C J, BettsCD, Christmas TJ,et al. Botulinum toxin in the treat- ment of chronic urinary retention in women. Br J Urol, 1992,70: 387- 389.
  • 8Leippold T, Reitz A, Schurch B. Botulinum toxin as a new thera- pyoption for voiding disorders: current state of the art. Eur Urol,2003, 44 : 165-174.
  • 9Cote RJ, Burke H, Schoenberg HW. Prediction of unusual postopera- tive results by urodynamic testing in benign prostatic hyperplasia. J Urol, 1981,125:6907592.
  • 10Chert SL, Bib LI, Chen GD, et al. Transrectal ultrasound-guided trans- perineal botulinum toxin A injection to the external urethral sphincter for treatment of detrusor external sphincter dyssynergiain patients with spinal cord injury. Arch Phys Med Rehabil,2010,91:340-344.

共引文献14

同被引文献59

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部